My PCR
Create Account
Logo PCR

21 May 2026

Stents, scaffolds and DCB

Complex coronary artery intervention: how DCB can help us

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: M. Belmonte, J. Loh
Speakers: L. Danduch, F. Erdogan, N. Corballis, W. Chu, J. Zhang, I. Hadzibegovic

Summary

This session delves into the role of Drug-Coated Balloons (DCB) in managing complex coronary artery interventions. It covers DCB-based PCI approaches in challenging lesions, compares clinical outcomes between Paclitaxel-coated balloon-only PCI and other strategies, and evaluates the effectiveness of DCB versus Drug-Eluting Stents (DES) in de novo coronary artery disease. The discussion further explores hybrid strategies combining DCB and DES, particularly in acute coronary syndromes, offering real-world insights.

Presentations available when logged in:

  • DCB-based PCI in complex coronary lesions
  • Clinical outcomes of Paclitaxel-coated balloon - Only PCI in complex coronary lesions
  • DCB only vs. hybrid strategy for de novo coronary artery disease within a DCB-based PCI approach
  • Hybrid strategy with DCB vs. stent only strategy for CBL
  • DCB, DES and hybrid strategies in acute coronary syndromes: real-world experience
Related Content
Sirolimus-Eluting Balloon vs. Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary... A novel bailout technique for the percutaneous extraction of an entrapped coronary guidewire beneath a crushed stent The next frontier of DCB is to simplify complexity
Recommended for you
AICT-AsiaPCR 2026 Call for Submissions IRONMAN II: 2-year outcomes of sirolimus-eluting bioresorbable scaffolds vs. DES PCRonline @ TCT 2025 - The international perspective